%0 Journal Article
%T The utility of pharmacogenetic testing to support the treatment of bipolar disorder
%A Alessandro Grecchi
%A Camilla Callegari
%A Ivano Caselli
%A Jordi Espadaler
%A Marta Ielmini
%A Miquel Tuson
%A Nicola Poloni
%J Archive of "Pharmacogenomics and Personalized Medicine".
%D 2018
%R 10.2147/PGPM.S160967
%X Bipolar disorder (BD) is a frequent cause of disability, health care costs, and risk of suicide. Pharmacogenetic tests (PGTs) could help clinicians to identify those patients predisposed to the occurrence of adverse events (AEs) improving the understanding of the correlation between genetic variants and drug response
%K pharmacogenetics testing
%K bipolar disorder
%K personalized medicine
%K pharmacogenetics
%K adverse events
%K tolerability
%K mood disorder
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860421/